See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Janne Marvola

https://www.etis.ee/CV/Janne_Marvola/est
5.05.1974
+358505454604
janne.marvola@gmail.com

Kvalifikatsioon

Teaduskraadid
Janne Marvola, doktorikraad, 2008, (juh) Marjo Yliperttula ; Arto Urtti, Neutron Activation-Based Gamma Scintigraphic Imaging and Scintigraphy-Based Pharmacokinetic Modelling of Per Oral Controlled Release Drug Delivery, Helsingi Ülikool.
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.3. Farmaatsia; CERCS KLASSIFIKAATOR: T410 Farmaatsiatooted ja nende tehnoloogiad
8.05.2018

Janne Marvola

https://www.etis.ee/CV/Janne_Marvola/eng
5.05.1974
+358505454604
janne.marvola@gmail.com

Career

Institutions and positions
01.01.2009–31.12.2010   
University of Helsinki, Faculty of Pharmacy, Education coordinator
01.01.2008–31.12.2009   
University of Helsinki, Faculty of Pharmacy, University Lecturer (acting)
01.01.2002–31.12.2007   
University of Helsinki, Faculty of Pharmacy, Researcher
01.01.2002–31.12.2003   
Remedium Oy (Encorium Oy), Consultant (secondary job)
01.01.2001–31.12.2010   
University of Helsinki, Faculty of Pharmacy, Lecturer in Information Technology (secondary job)
01.01.2000–31.12.2001   
University of Helsinki, Faculty of Pharmacy, Research assistant
01.01.1998–31.12.1998   
University of Helsinki, Faculty of Pharmacy, Academic Secretary (acting)
01.01.1997–31.12.1998   
Helsinki University of Technology, Laboratory of Biomedical Engineering, Research assistant

Qualifications

Academic degrees
Janne Marvola, Doctor's Degree, 2008, (sup) Marjo Yliperttula ; Arto Urtti, Neutron Activation-Based Gamma Scintigraphic Imaging and Scintigraphy-Based Pharmacokinetic Modelling of Per Oral Controlled Release Drug Delivery, University of Helsinki.
Janne Marvola, Research Master's Degree, 2004, (sup) Professor Toivo Katila, Stability of some pharmaceutical excipients and dosage forms during neutron activation and establishment of in vivo gamma scintigraphic imaging methods, Helsinki University of Technology.
 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.3. Pharmacy; CERCS CLASSIFICATION: T410 Pharmaceuticals and related technologies
ETIS CLASSIFICATION: 4. Natural Sciences and Engineering; 4.6. Computer Sciences; CERCS CLASSIFICATION: P170 Computer science, numerical analysis, systems, control
ETIS CLASSIFICATION: 4. Natural Sciences and Engineering; 4.9. Medical Engineering; CERCS CLASSIFICATION: B140 Clinical physics, radiology, tomography, medical instrumentation

Publications

Category
Year
Publication
 
1.1.
2008
Marvola, Tuuli; Marvola, Janne; Kanerva, Hanna; Ahonen, Aapo; Lindevall, Kai; Marvola, Martti (2008). Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon. International Journal of Pharmaceutics, 349, 24−29.
5.1.
2008
Marvola, J.; Urtti, A.; Yliperttula, M. (2008). Developing an extended compartmental absorption and transit model for per oral controlled drug delivery. European Journal of Pharmaceutical Sciences, 34 (1), S39.
5.1.
2007
Marvola, J.; Yliperttula, M.; Urtti, A. (2007). Compartmental absorption and transit model of human small intestine and colon based on a pharmacoscintigraphic in vivo study with caffeine. European Journal of Pharmaceutical Sciences, 32 (1), 7−8.
5.1.
2007
Marvola, T.; Mahlamäki, S.; Kreutzwald, P.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Marvola, M. (2007). Site-specific L-cysteine formulations for preservation of cancer in stomach and colon. European Journal of Pharmaceutical Sciences, 32: 2nd BBBB Conference on Pharmaceutical Sciences;Tallinn-Tartu; September 13-15, 2007. Elsevier Science BV, S6. (Issue 1, Suppl).
1.1.
2006
Säkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Ahonen, Aapo; Marvola, Martti (2006). Are chitosan formulations mucoadhesive in the human small intestine?: An evaluation based on gamma scintigraphy. International Journal of Pharmaceutics, 307, 285−291.
3.4.
2005
Marvola, T.; Suuronen, M.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Kreutzwald, P.; Marvola, M. (2005). In vivo evaluation of enteric coated HPMC-capsules for the colonic drug delivery. 1st BBBB Conference on Pharmaceutical Sciences. Siofok, 183−185.
1.1.
2004
Marvola, Janne; Kanerva, Hanna; Slot, Lillian; Lipponen, Maija; Kekki, Tommi; Hietanen, Heikki; Mykkänen, Sirpa; Ariniemi, Kari; Lindevall, Kai; Marvola, Martti (2004). Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet® constant-release drug delivery system. International Journal of Pharmaceutics, 281, 3−10.
1.1.
2004
Säkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Ahonen, Aapo; Marvola, Martti (2004). Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus. European Journal of Pharmaceutics and Biopharmaceutics, 57, 145−147.
1.1.
2004
Säkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Lipponen, Maija; Kekki, Tommi; Ahonen, Aapo; Marvola, Martti (2004). Gamma scintigraphic evaluation of the fate of microcrystalline chitosan granules in human stomach. European Journal of Pharmaceutics and Biopharmaceutics, 57, 133−134.
1.1.
2002
Honkanen, Outi; Laaksonen, Pia; Marvola, Janne; Eerikäinen, Sari; Tuominen, Raimo; Marvola, Martti (2002). Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations. European Journal of Pharmaceutical Sciences, 15, 479−488.
1.1.
2001
Honkanen, Outi; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Lipponen, Maija; Kekki, Tommi; Ahonen, Aapo; Marvola, Martti (2001). Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tract. European Journal of Pharmaceutical Sciences, 21, 671−678.
8.05.2018

Otsi publikatsiooni

  • {{item.Name}}
 kuni 
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 11 kirjet
PublikatsioonAutoridAastaVäljaande pealkiriKlassifikaatorFailAsutused
Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colonMarvola, Tuuli; Marvola, Janne; Kanerva, Hanna; Ahonen, Aapo; Lindevall, Kai; Marvola, Martti2008International Journal of Pharmaceutics1.1.Helsingi Ülikool
Developing an extended compartmental absorption and transit model for per oral controlled drug deliveryMarvola, J.; Urtti, A.; Yliperttula, M.2008European Journal of Pharmaceutical Sciences5.1.Helsingi Ülikool
Compartmental absorption and transit model of human small intestine and colon based on a pharmacoscintigraphic in vivo study with caffeineMarvola, J.; Yliperttula, M.; Urtti, A.2007European Journal of Pharmaceutical Sciences5.1.Helsingi Ülikool
Site-specific L-cysteine formulations for preservation of cancer in stomach and colonMarvola, T.; Mahlamäki, S.; Kreutzwald, P.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Marvola, M.2007European Journal of Pharmaceutical Sciences5.1.Tartu Ülikool, Arstiteaduskond, Farmaatsia instituut;
Tartu Ülikool, Arstiteaduskond, Farmaatsia instituut, Ravimite tehnoloogia ja biofarmaatsia õppetool;
Helsingi Ülikool
Are chitosan formulations mucoadhesive in the human small intestine?: An evaluation based on gamma scintigraphySäkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Ahonen, Aapo; Marvola, Martti2006International Journal of Pharmaceutics1.1.Helsingi Ülikool
In vivo evaluation of enteric coated HPMC-capsules for the colonic drug deliveryMarvola, T.; Suuronen, M.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Kreutzwald, P.; Marvola, M.20051st BBBB Conference on Pharmaceutical Sciences3.4.Tartu Ülikool;
Helsingi Ülikool
Gamma scintigraphic evaluation of the fate of microcrystalline chitosan granules in human stomachSäkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Lipponen, Maija; Kekki, Tommi; Ahonen, Aapo; Marvola, Martti2004European Journal of Pharmaceutics and Biopharmaceutics1.1.Helsingi Ülikool
Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet® constant-release drug delivery systemMarvola, Janne; Kanerva, Hanna; Slot, Lillian; Lipponen, Maija; Kekki, Tommi; Hietanen, Heikki; Mykkänen, Sirpa; Ariniemi, Kari; Lindevall, Kai; Marvola, Martti2004International Journal of Pharmaceutics1.1.Helsingi Ülikool
Scintigraphic verification of adherence of a chitosan formulation to the human oesophagusSäkkinen, Mia; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Ahonen, Aapo; Marvola, Martti2004European Journal of Pharmaceutics and Biopharmaceutics1.1.Helsingi Ülikool
Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulationsHonkanen, Outi; Laaksonen, Pia; Marvola, Janne; Eerikäinen, Sari; Tuominen, Raimo; Marvola, Martti2002European Journal of Pharmaceutical Sciences1.1.Helsingi Ülikool
Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tractHonkanen, Outi; Marvola, Janne; Kanerva, Hanna; Lindevall, Kai; Lipponen, Maija; Kekki, Tommi; Ahonen, Aapo; Marvola, Martti2001European Journal of Pharmaceutical Sciences1.1.Helsingi Ülikool